Literature DB >> 2402723

Evidence for protein oedema, neutrophil influx, and enhanced collagen production in lungs of patients with systemic sclerosis.

N K Harrison1, R J McAnulty, P L Haslam, C M Black, G J Laurent.   

Abstract

Bronchoalveolar lavage fluid from patients with systemic sclerosis was analysed for evidence of pulmonary vascular leakage, inflammatory cell influx, and enhanced type III collagen synthesis. Eighteen patients with systemic sclerosis and computed tomographic evidence of fibrosing alveolitis were compared with 16 patients with a normal scan. The albumin concentration in lavage fluid was higher in all patients than in normal volunteers. Patients with an abnormal computed tomogram as a group had increased proportions of all inflammatory cell types, whereas those with a normal scan had increased neutrophils only. Increased lavage type III procollagen peptides were found in all patients with an abnormal computed tomogram and eight of those with a normal scan. These results suggest that pulmonary vascular leakage and neutrophil influx may be early pathological features of lung disease in systemic sclerosis and frequently associated with enhanced collagen production. Thus lavage of patients with systemic sclerosis may identify lung inflammation and altered collagen metabolism early in the evolution of fibrosing alveolitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2402723      PMCID: PMC462642          DOI: 10.1136/thx.45.8.606

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  30 in total

1.  Pulmonary scleroderma.

Authors:  A L Weaver; M B Divertie; J L Titus
Journal:  Dis Chest       Date:  1968-12

2.  Control of collagen production by human diploid lung fibroblasts.

Authors:  S D Breul; K H Bradley; A J Hance; M P Schafer; R A Berg; R G Crystal
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

3.  Radioimmunoassay for type III procollagen peptide and its application to human liver disease.

Authors:  H Rohde; L Vargas; E Hahn; H Kalbfleisch; M Bruguera; R Timpl
Journal:  Eur J Clin Invest       Date:  1979-12       Impact factor: 4.686

4.  Lung involvement in scleroderma.

Authors:  G König; C Luderschmidt; C Hammer; B C Adelmann-Grill; O Braun-Falco; G Fruhmann
Journal:  Chest       Date:  1984-03       Impact factor: 9.410

5.  Serum and urine analysis of the aminoterminal procollagen peptide type III by radioimmunoassay with antibody Fab fragments.

Authors:  H Rohde; I Langer; T Krieg; R Timpl
Journal:  Coll Relat Res       Date:  1983-09

6.  Biochemical evidence for an increased and progressive deposition of collagen in lungs of patients with pulmonary fibrosis.

Authors:  J M Kirk; P E Da Costa; M Turner-Warwick; R J Littleton; G J Laurent
Journal:  Clin Sci (Lond)       Date:  1986-01       Impact factor: 6.124

7.  Bleomycin-induced pulmonary fibrosis in the rat: inhibition by indomethacin.

Authors:  R S Thrall; J R McCormick; R M Jack; R A McReynolds; P A Ward
Journal:  Am J Pathol       Date:  1979-04       Impact factor: 4.307

8.  Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis.

Authors:  G A Rossi; P B Bitterman; S I Rennard; V J Ferrans; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1985-04

9.  Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance.

Authors:  N K Harrison; A R Glanville; B Strickland; P L Haslam; B Corrin; B J Addis; R Lawrence; A B Millar; C M Black; M Turner-Warwick
Journal:  Respir Med       Date:  1989-09       Impact factor: 3.415

10.  Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage.

Authors:  R M Silver; J F Metcalf; J H Stanley; E C LeRoy
Journal:  Arthritis Rheum       Date:  1984-11
View more
  4 in total

1.  Role of semaphorin 7a signaling in transforming growth factor β1-induced lung fibrosis and scleroderma-related interstitial lung disease.

Authors:  Ye Gan; Ronald Reilkoff; Xueyan Peng; Thomas Russell; Qingsheng Chen; Susan K Mathai; Robert Homer; Mridu Gulati; Jonathan Siner; Jack Elias; Richard Bucala; Erica Herzog
Journal:  Arthritis Rheum       Date:  2011-08

2.  Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension.

Authors:  S A Kharitonov; J B Cailes; C M Black; R M du Bois; P J Barnes
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

3.  Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis.

Authors:  M R Hussein; H I Hassan; E R M Hofny; M Elkholy; N A Fatehy; A E A Abd Elmoniem; A M Ezz El-Din; O A Afifi; H G Rashed
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

4.  Imaging of pulmonary disease in scleroderma with J001X scintigraphy.

Authors:  P Diot; E Diot; E Lemarie; J L Guilmot; J L Baulieu; E Asquier; C Valat; A Delarue; A Le Pape
Journal:  Thorax       Date:  1994-05       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.